Company Filing History:
Years Active: 2025
Title: Scott V Bratman: Innovator in Tumor Marker Detection
Introduction
Scott V Bratman is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of cancer diagnostics through his innovative research and patented methods. His work focuses on the identification and use of circulating nucleic acid tumor markers, which are crucial for monitoring disease progression.
Latest Patents
Scott V Bratman holds a patent for "Identification and use of circulating nucleic acid tumor markers." This patent describes methods for creating a selector of mutated genomic regions and utilizing this selector to analyze genetic alterations in cell-free nucleic acid samples. The methods outlined in the patent can measure tumor-derived nucleic acids in blood samples, enabling the monitoring of disease progression. Additionally, these methods are applicable for cancer screening, diagnosis, prognosis, and therapy designation.
Career Highlights
Bratman is affiliated with Leland Stanford Junior University, where he continues to advance research in cancer diagnostics. His work has the potential to significantly impact how cancer is detected and treated, providing valuable insights into patient care.
Collaborations
Scott V Bratman has collaborated with esteemed colleagues, including Maximilian Diehn and Arash Ash Alizadeh. These collaborations enhance the research efforts in the field of oncology and contribute to the development of innovative diagnostic tools.
Conclusion
Scott V Bratman is a pioneering inventor whose work in tumor marker detection is shaping the future of cancer diagnostics. His contributions are vital for improving patient outcomes and advancing medical research.